King’s College London, one of the top 25 universities in the world, is teaming up with Parkinson’s UK for a £1.2-million clinical trial to determine the safety and efficacy of CBD in treating Parkinson’s-related psychosis, characterized by hallucinations and delusions.
The clinical trial will determine, for the first time, whether CBD can correct the abnormal functioning of the brain that is causing symptoms such as hallucinations and delusions.
The University of Colorado School of Medicine is conducting a phase two clinical trial to determine if CBD can reduce symptoms of Parkinson’s disease
Aurora’s CanniMed cannabis-oil products to be used in a clinical trial for Parkinson’s disease.
The study will determine the safety and tolerability of three different formulations of the cannabis oil for pain in Parkinson’s patients.
At University of Colorado, approximately 60 people will participate in a clinical trial with hopes that CBD will relieve some of the troubling symptoms of Parkinson’s Disease.
GW Pharmaceuticals is conducting a clinical trial on the effectiveness of its #CBD drug in treating tremors in #Parkinson’s Disease.
The company said it expects to complete the study in June 2019.
Cannabis may have a beneficial effect on mood, memory, fatigue and possibly obesity in patients suffering Parkinson’s Disease and Multiple Sclerosis, according to web-based research conducted by Colorado State University through the Michael J. Fox Foundation and National Multiple Sclerosis Society.
Can THC protect the brain in Alzheimer’s, Parkinson’s, Huntington’s? Experimental research shows it’s prossible.
Experimental research shows that cannabinoid receptors are increased in areas where lesions have formed in the brain.